• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型转甲状腺素蛋白淀粉样变性心肌病患者左心房应变的预后价值。

Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy.

机构信息

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences, Kumamoto, Japan.

出版信息

ESC Heart Fail. 2021 Dec;8(6):5316-5326. doi: 10.1002/ehf2.13621. Epub 2021 Sep 28.

DOI:10.1002/ehf2.13621
PMID:34582129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8712780/
Abstract

AIMS

This study was performed to investigate whether left atrial (LA) strain by echocardiography provides prognostic information in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM).

METHODS AND RESULTS

Among 129 patients who were diagnosed with ATTRwt-CM at Kumamoto University Hospital from December 2002 to December 2019, 113 patients who had enough information for two-dimensional speckle tracking echocardiography were enrolled in this study. During a median follow-up of 668 days, 28 cardiovascular deaths occurred. Compared with patients in the non-event group, those in the cardiovascular death group were significantly older (81.5 ± 7.4 vs. 78.1 ± 6.1 years, P < 0.01), had a lower incidence of carpal tunnel syndrome (21% vs. 47%, P < 0.05), and had a higher high-sensitivity cardiac troponin T [0.085 (0.063-0.105) vs. 0.049 (0.036-0.079) ng/mL, P < 0.01] and B-type natriuretic peptide concentrations [419 (239-541) vs. 271 (155-462) pg/mL, P < 0.01] and lower estimated glomerular filtration rate (41.8 ± 15.4 vs. 53.4 ± 14.6 mL/min/1.73 m , P < 0.01). Electrocardiography showed higher rate of a V1-V3 QS pattern (52% vs. 24%, P < 0.01) and complete left bundle branch block (27% vs. 6%, P < 0.01), and echocardiography showed a significantly lower peak LA strain rate during the contraction phase (0.16 ± 0.13 vs. 0.28 ± 0.27 S , P < 0.05), LA strain during the reservoir phase (LASr) (5.84 ± 2.41 vs. 8.22 ± 4.05%, P < 0.01), and peak LA strain rate during the reservoir phase (0.26 ± 0.09 vs. 0.33 ± 0.15 S , P < 0.05) in the cardiovascular death group than in non-event group. By contrast, conventional echocardiographic findings were not significantly different between these two groups. After adjusting for conventional predictive factors of ATTRwt-CM (age, high-sensitivity cardiac troponin T and B-type natriuretic peptide concentrations, and estimated glomerular filtration rate), multivariable Cox proportional hazard analyses showed that LASr was significantly and independently associated with cardiovascular death in patients with ATTRwt-CM (odds ratio, 0.84; 95% confidence interval, 0.72-0.98; P < 0.05). After adjusting for age and echocardiographic findings associated with cardiovascular death (LA volume index and peak LA strain rate during the contraction phase), LASr was significantly and independently associated with cardiovascular death in patients with ATTRwt-CM (odds ratio, 0.83; 95% confidence interval, 0.70-0.98; P < 0.05). Receiver operating characteristic curve analysis showed that the area under the curve of LASr for cardiovascular death was 0.686 and that the best cut-off value of LASr was 6.69% (sensitivity, 62.4%; specificity, 64.3%). In the Kaplan-Meier analysis, patients with low LASr (<6.69%) had a significantly higher probability of total cardiovascular death (P < 0.05) and heart failure-related hospitalization (P < 0.05).

CONCLUSIONS

Left atrial strain during the reservoir phase provides significant prognostic value in patients with ATTRwt-CM even after adjusting for conventional predictive factors.

摘要

目的

本研究旨在探讨左心房应变(LA)通过超声心动图提供预后信息在野生型转甲状腺素蛋白淀粉样心肌病(ATTRwt-CM)患者。

方法和结果

在从 2002 年 12 月至 2019 年 12 月期间在熊本大学医院诊断为 ATTRwt-CM 的 129 名患者中,纳入了 113 名具有足够二维斑点追踪超声心动图信息的患者。在中位随访 668 天期间,发生了 28 例心血管死亡事件。与非事件组相比,心血管死亡组的患者年龄明显更大(81.5±7.4 岁 vs. 78.1±6.1 岁,P<0.01),腕管综合征的发生率更低(21% vs. 47%,P<0.05),高敏心肌肌钙蛋白 T [0.085(0.063-0.105)ng/ml vs. 0.049(0.036-0.079)ng/ml,P<0.01]和 B 型利钠肽浓度[419(239-541)pg/ml vs. 271(155-462)pg/ml,P<0.01]更高,估算肾小球滤过率(eGFR)更低(41.8±15.4 vs. 53.4±14.6 ml/min/1.73 m ,P<0.01)。心电图显示更高的 V1-V3 QS 模式(52% vs. 24%,P<0.01)和完全左束支传导阻滞(27% vs. 6%,P<0.01),超声心动图显示收缩期峰值 LA 应变率明显更低(0.16±0.13 vs. 0.28±0.27 S ,P<0.05),心房储备期 LA 应变(LASr)(5.84±2.41 vs. 8.22±4.05%,P<0.01)和心房储备期峰值 LA 应变率(0.26±0.09 vs. 0.33±0.15 S ,P<0.05)在心血管死亡组比非事件组。相比之下,两组之间的常规超声心动图发现没有显著差异。在调整 ATTRwt-CM 的常规预测因素(年龄、高敏心肌肌钙蛋白 T 和 B 型利钠肽浓度以及 eGFR)后,多变量 Cox 比例风险分析显示,LASr 与 ATTRwt-CM 患者的心血管死亡显著且独立相关(优势比,0.84;95%置信区间,0.72-0.98;P<0.05)。在调整与心血管死亡相关的年龄和超声心动图发现(左心房容积指数和收缩期峰值 LA 应变率)后,LASr 与 ATTRwt-CM 患者的心血管死亡显著且独立相关(优势比,0.83;95%置信区间,0.70-0.98;P<0.05)。接受者操作特征曲线分析显示,LASr 用于心血管死亡的曲线下面积为 0.686,最佳 LASr 截断值为 6.69%(敏感性,62.4%;特异性,64.3%)。在 Kaplan-Meier 分析中,LASr 较低(<6.69%)的患者总心血管死亡的可能性显著更高(P<0.05)和心力衰竭相关住院(P<0.05)。

结论

即使在调整常规预测因素后,心房储备期 LA 应变在 ATTRwt-CM 患者中提供了显著的预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/37387f23f310/EHF2-8-5316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/71f5ef099c68/EHF2-8-5316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/93e5b14fc044/EHF2-8-5316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/d9968e3370a8/EHF2-8-5316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/37387f23f310/EHF2-8-5316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/71f5ef099c68/EHF2-8-5316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/93e5b14fc044/EHF2-8-5316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/d9968e3370a8/EHF2-8-5316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b3f/8712780/37387f23f310/EHF2-8-5316-g004.jpg

相似文献

1
Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy.野生型转甲状腺素蛋白淀粉样变性心肌病患者左心房应变的预后价值。
ESC Heart Fail. 2021 Dec;8(6):5316-5326. doi: 10.1002/ehf2.13621. Epub 2021 Sep 28.
2
Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy.转甲状腺素蛋白淀粉样变心肌病患者右心室整体纵向应变的预后价值。
J Cardiol. 2022 Jul;80(1):56-63. doi: 10.1016/j.jjcc.2022.02.010. Epub 2022 Mar 10.
3
A new staging system using right atrial strain in patients with immunoglobulin light-chain cardiac amyloidosis.采用右心房应变的新分期系统用于免疫球蛋白轻链心脏淀粉样变患者。
ESC Heart Fail. 2024 Jun;11(3):1612-1624. doi: 10.1002/ehf2.14710. Epub 2024 Feb 23.
4
Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis.左心房和心室应变在诊断主动脉瓣狭窄伴转甲状腺素蛋白淀粉样变心肌病中的作用。
ESC Heart Fail. 2022 Jun;9(3):1976-1986. doi: 10.1002/ehf2.13909. Epub 2022 Mar 25.
5
A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan.日本一种使用生物标志物的简单分期系统用于野生型转甲状腺素蛋白淀粉样心肌病。
ESC Heart Fail. 2022 Jun;9(3):1731-1739. doi: 10.1002/ehf2.13847. Epub 2022 Feb 22.
6
Prognostic values of left atrial strain analyzed by four-dimensional speckle tracking echocardiography in uremia with preserved ejection fraction.四维斑点追踪超声心动图分析左房应变对射血分数保留的尿毒症患者的预后价值。
Sci Rep. 2024 Aug 16;14(1):18971. doi: 10.1038/s41598-024-69904-4.
7
Left atrial reservoir strain is an outstanding predictor of adverse cardiovascular outcomes in patients undergoing maintenance hemodialysis: Assessment via three-dimensional speckle tracking echocardiography.左心房储器应变是维持性血液透析患者不良心血管结局的杰出预测因子:三维斑点追踪超声心动图评估。
Clin Cardiol. 2022 May;45(5):549-557. doi: 10.1002/clc.23815. Epub 2022 Mar 21.
8
Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan.日本野生型转甲状腺素蛋白淀粉样心肌病的临床特征与自然病史
ESC Heart Fail. 2020 Oct;7(5):2829-2837. doi: 10.1002/ehf2.12884. Epub 2020 Jul 16.
9
Effect of tafamidis on left atrial function of patients with transthyretin amyloid cardiomyopathy.塔法米迪司对转甲状腺素蛋白淀粉样心肌病患者左心房功能的影响。
Heart Vessels. 2024 Sep;39(9):810-817. doi: 10.1007/s00380-024-02402-9. Epub 2024 May 14.
10
Four-dimensional quantification on left atrial volume-strain in coronary heart disease patients without regional wall motion abnormalities: Correlation with the severity of coronary stenosis.冠心病患者左心房容积应变的四维定量:与冠状动脉狭窄严重程度的相关性。
Echocardiography. 2022 Jun;39(6):758-767. doi: 10.1111/echo.15355. Epub 2022 May 3.

引用本文的文献

1
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis.轻链和转甲状腺素蛋白淀粉样变性的超声心动图风险分层:一项荟萃分析。
Eur Heart J Open. 2025 Aug 22;5(4):oeaf078. doi: 10.1093/ehjopen/oeaf078. eCollection 2025 Jul.
2
Left Atrial Strain-Current Review of Clinical Applications.左心房应变——临床应用的当前综述
Diagnostics (Basel). 2025 May 27;15(11):1347. doi: 10.3390/diagnostics15111347.
3
Clinical significance of the estimation of pulmonary-right ventricular uncoupling in patients with transthyretin amyloid cardiomyopathy.

本文引用的文献

1
Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis.超声心动图心房和心室应变成像在心脏淀粉样变性患者中的预后价值。
JACC Cardiovasc Imaging. 2021 Aug;14(8):1508-1519. doi: 10.1016/j.jcmg.2021.01.016. Epub 2021 Mar 17.
2
Usefulness of relative apical longitudinal strain index to predict positive Tc-labeled pyrophosphate scintigraphy findings in advanced-age patients with suspected transthyretin amyloid cardiomyopathy.相对心尖纵向应变指数在预测高龄疑似转甲状腺素蛋白淀粉样心肌病患者 Tc 标记焦磷酸盐闪烁显像阳性结果中的作用。
Echocardiography. 2020 Nov;37(11):1774-1783. doi: 10.1111/echo.14892. Epub 2020 Nov 4.
3
转甲状腺素蛋白淀粉样变心肌病患者肺-右心室解耦联评估的临床意义
Eur Heart J Imaging Methods Pract. 2025 Jan 17;3(1):qyae113. doi: 10.1093/ehjimp/qyae113. eCollection 2025 Jan.
4
Prognostic value of left atrial stiffness in patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术患者左心房僵硬度的预后价值
Int J Cardiol Heart Vasc. 2024 Dec 24;56:101559. doi: 10.1016/j.ijcha.2024.101559. eCollection 2025 Feb.
5
The Clinical Applications of Left Atrial Strain: A Comprehensive Review.左房应变的临床应用:全面综述。
Medicina (Kaunas). 2024 Apr 24;60(5):693. doi: 10.3390/medicina60050693.
6
Effect of tafamidis on left atrial function of patients with transthyretin amyloid cardiomyopathy.塔法米迪司对转甲状腺素蛋白淀粉样心肌病患者左心房功能的影响。
Heart Vessels. 2024 Sep;39(9):810-817. doi: 10.1007/s00380-024-02402-9. Epub 2024 May 14.
7
Incremental diagnostic and prognostic utility of left atrial deformation in heart failure using speckle tracking echocardiography.斑点追踪超声心动图检测左心房应变在心力衰竭中的诊断和预后价值。
Heart Fail Rev. 2024 May;29(3):713-727. doi: 10.1007/s10741-024-10392-z. Epub 2024 Mar 11.
8
Left ventricular and atrial myocardial strain in heart failure with preserved ejection fraction: the evidence so far and prospects for phenotyping strategy.射血分数保留的心力衰竭患者的左心室和心房心肌应变:目前的证据及表型策略展望
Cardiovasc Ultrasound. 2024 Mar 4;22(1):4. doi: 10.1186/s12947-024-00323-1.
9
Takotsubo syndrome: left atrial and ventricular myocardial strain impairment in the subacute and convalescent phases assessed by CMR.心尖球形综合征:CMR 评估亚急性期和恢复期左心房和左心室心肌应变损伤。
Eur Radiol Exp. 2024 Feb 28;8(1):34. doi: 10.1186/s41747-024-00423-7.
10
A new staging system using right atrial strain in patients with immunoglobulin light-chain cardiac amyloidosis.采用右心房应变的新分期系统用于免疫球蛋白轻链心脏淀粉样变患者。
ESC Heart Fail. 2024 Jun;11(3):1612-1624. doi: 10.1002/ehf2.14710. Epub 2024 Feb 23.
Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan.
日本野生型转甲状腺素蛋白淀粉样心肌病的临床特征与自然病史
ESC Heart Fail. 2020 Oct;7(5):2829-2837. doi: 10.1002/ehf2.12884. Epub 2020 Jul 16.
4
Clinical significance of diastolic late mitral annular velocity in heart failure with preserved ejection fraction.舒张晚期二尖瓣环速度在射血分数保留的心力衰竭中的临床意义
Int J Cardiol. 2020 Oct 1;316:145-151. doi: 10.1016/j.ijcard.2020.03.077. Epub 2020 Apr 2.
5
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
6
Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.二维斑点追踪超声心动图左心房、右心室和右心房应变成像标准化:EACVI/ASE/Industry 工作组标准化应变成像的共识文件。
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):591-600. doi: 10.1093/ehjci/jey042.
7
Recent advances in diagnosis and treatment of cardiac amyloidosis.心脏淀粉样变性诊断与治疗的最新进展
J Cardiol. 2018 Feb;71(2):135-143. doi: 10.1016/j.jjcc.2017.10.003. Epub 2017 Nov 5.
8
A new staging system for cardiac transthyretin amyloidosis.心脏转甲状腺素蛋白淀粉样变性的新分期系统。
Eur Heart J. 2018 Aug 7;39(30):2799-2806. doi: 10.1093/eurheartj/ehx589.
9
Left atrial structure and function in cardiac amyloidosis.心脏淀粉样变性中的左心房结构和功能。
Eur Heart J Cardiovasc Imaging. 2017 Oct 1;18(10):1128-1137. doi: 10.1093/ehjci/jex097.
10
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.野生型转甲状腺素蛋白心脏淀粉样变性的自然病史和使用新型分期系统进行风险分层。
J Am Coll Cardiol. 2016 Sep 6;68(10):1014-20. doi: 10.1016/j.jacc.2016.06.033.